Medacta Group SA (MOVE) - Total Liabilities
Based on the latest financial reports, Medacta Group SA (MOVE) has total liabilities worth CHF436.15 Million CHF (≈ $551.42 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore MOVE long-term investments to assets to see how much of total assets are deployed in long-term investments.
Medacta Group SA - Total Liabilities Trend (2015–2024)
This chart illustrates how Medacta Group SA's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see MOVE total assets.
Medacta Group SA Competitors by Total Liabilities
The table below lists competitors of Medacta Group SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
IHS Holding Ltd
NYSE:IHS
|
USA | $4.69 Billion |
|
Henan Yuneng Holdings Co Ltd
SHE:001896
|
China | CN¥27.92 Billion |
|
Deppon Logistics Co Ltd
SHG:603056
|
China | CN¥8.09 Billion |
|
NetScout Systems Inc
NASDAQ:NTCT
|
USA | $647.81 Million |
|
Anhui Expressway Co Ltd
SHG:600012
|
China | CN¥15.18 Billion |
|
K+S Aktiengesellschaft
XETRA:SDF
|
Germany | €2.88 Billion |
|
People.Cn Co Ltd
SHG:603000
|
China | CN¥1.37 Billion |
|
Medical Properties Trust Inc
NYSE:MPW
|
USA | $10.22 Billion |
Liability Composition Analysis (2015–2024)
This chart breaks down Medacta Group SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Medacta Group SA (MOVE) balance sheet quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medacta Group SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medacta Group SA (2015–2024)
The table below shows the annual total liabilities of Medacta Group SA from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CHF412.51 Million ≈ $521.53 Million |
+12.76% |
| 2023-12-31 | CHF365.83 Million ≈ $462.51 Million |
+18.07% |
| 2022-12-31 | CHF309.83 Million ≈ $391.71 Million |
+17.87% |
| 2021-12-31 | CHF262.87 Million ≈ $332.34 Million |
-5.18% |
| 2020-12-31 | CHF277.22 Million ≈ $350.48 Million |
-4.19% |
| 2019-12-31 | CHF289.33 Million ≈ $365.79 Million |
+4.63% |
| 2018-12-31 | CHF276.53 Million ≈ $349.60 Million |
+39.56% |
| 2017-12-31 | CHF198.14 Million ≈ $250.50 Million |
+61.34% |
| 2016-12-31 | CHF122.81 Million ≈ $155.27 Million |
+11.35% |
| 2015-12-31 | CHF110.29 Million ≈ $139.44 Million |
-- |
About Medacta Group SA
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.